Published by GlobalData, Yahoo Finance on May 16, 2025
Israeli mental health technology company GrayMatters Health (GMH) has launched Prism Suite, a set of solutions designed to support healthcare providers and improve patient outcomes in mental health care.
The suite features a depression protocol and utilises functional magnetic resonance imaging (fMRI) informed digital biomarkers to help patients manage their condition.
It builds on the company’s Prism solution for managing post-traumatic stress disorder (PTSD), which has been approved by the US Food and Drug Administration (FDA).
Prism Suite is designed to assist patients with depression by using a reward-system biomarker to regulate brain activity linked to their symptoms.
Patients engage with the programme by adopting mental strategies that animate a character in a simulation, encouraging them to undertake activities.
The suite also offers a range of tools for healthcare providers, which aim to enable the monitoring of patient progress and deliver insights into the patient experience, potentially improving engagement.
Continue reading at Yahoo Finance
GrayMatters Health is co-founded by alumni Oded Kraft and Shai Attia.
